Vaccines to Prevent Dengue Fever Advanced Tech

Abstract

This Project covers technology development, demonstration and transition of a candidate vaccine for the prevention of Dengue fever caused by any of the four Dengue virus serotypes. The vaccine is intended to be effective in people with and without a prior history of Dengue infection. Research is conducted in compliance with FDA regulations for medical products for human use. Promising medical countermeasures identified in this Project are further matured under Program Element 0603807A (Medical Systems Advanced Development), Project 808 (DoD Drug & Vacc Ad). The cited work is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. All FY20 adjustments align program resources to Army Modernization Priorities in support of the National Defense Strategy. Work is managed by the United States Army Medical Research and Development Command (USAMRDC) in coordination with the Naval Medical Research Center (NMRC). The Army is responsible for programming and funding all Department of Defense (DoD) naturally occurring infectious disease research requirements, thereby precluding duplication of effort within the Military Departments.

Open PDF

Document Details

Document Type
Project
Publication Date
Oct 01, 2022
Source ID
MO9_0603002A_3_2040_PB_2022

Tags

Readers

  • Infectious Disease/Epidemiology
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents